<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: bluebird bio Announces Early Data from Phase 3 Northstar-2 (HGB-207) Study of LentiGlobinTM Drug Product at European Hematology Association (EHA) Annual Meeting	</title>
	<atom:link href="https://www.novumpr.nl/2017/06/23/bluebird-bio-announces-early-data-from-phase-3-northstar-2-hgb-207-study-of-lentiglobintm-drug-product-at-european-hematology-association-eha-annual-meeting/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.novumpr.nl/2017/06/23/bluebird-bio-announces-early-data-from-phase-3-northstar-2-hgb-207-study-of-lentiglobintm-drug-product-at-european-hematology-association-eha-annual-meeting/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=bluebird-bio-announces-early-data-from-phase-3-northstar-2-hgb-207-study-of-lentiglobintm-drug-product-at-european-hematology-association-eha-annual-meeting</link>
	<description>NovumPR press releases</description>
	<lastBuildDate>Fri, 23 Jun 2017 14:59:00 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.8.3</generator>
</channel>
</rss>
